You are here

Article info

Article menu
Download PDFPDF
Editorial
Should inflammatory pathways be targeted for the prevention and treatment of hypertension?

Authors

  • Setor K Kunutsor National Institute for Health Research Bristol Biomedical Research Centre, University Hospitals Bristol NHS Foundation Trust and University of Bristol, Bristol, UK Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, University of Bristol, Learning & Research Building (Level 1), Southmead Hospital, Bristol, UK PubMed articlesGoogle scholar articles
  • Jari A Laukkanen Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland Department of Medicine, Central Finland Health Care District, Jyväskylä, Finland PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Jari A Laukkanen, Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä 40014, Finland; jari.a.laukkanen{at}jyu.fi
View Full Text

Citation

Kunutsor SK, Laukkanen JA
Should inflammatory pathways be targeted for the prevention and treatment of hypertension?
Heart 2019;105:665-667.

Publication history

  • First published January 30, 2019.
Online issue publication 
January 18, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.